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Presynaptic metabotropic glutamate receptors (mGluRs) show a highly selective expression and subcellular location in nerve terminals
modulatingneurotransmitter release.Wehavedemonstrated that alternatively splicedvariantsofmGluR8,mGluR8aandmGluR8b,have
an overlapping distribution in the hippocampus, and besides perforant path terminals, they are expressed in the presynaptic active zone
of boutons making synapses selectively with several types of GABAergic interneurons, primarily in the stratum oriens. Boutons labeled
for mGluR8 formed either type I or type II synapses, and the latter were GABAergic. Some mGluR8-positive boutons also expressed
mGluR7 or vasoactive intestinal polypeptide. Interneurons strongly immunopositive for themuscarinicM2 or themGlu1 receptors were
the primary targets ofmGluR8-containing terminals in the stratumoriens, but only neurochemically distinct subsets were innervated by
mGluR8-enriched terminals. Themajority ofM2-positive neuronsweremGluR8 innervated, but aminority, which expresses somatosta-
tin, was not. Rare neurons coexpressing calretinin andM2were consistently targeted bymGluR8-positive boutons. In vivo recording and
labeling of anmGluR8-decorated and stronglyM2-positive interneuron revealed a trilaminar cell with complex spike bursts during theta
oscillations and strong discharge during sharp wave/ripple events. The trilaminar cell had a large projection from the CA1 area to the
subiculum and a preferential innervation of interneurons in the CA1 area in addition to pyramidal cell somata and dendrites. The
postsynaptic interneuron type-specific expression of the high-efficacy presynaptic mGluR8 in both putative glutamatergic and in iden-
tified GABAergic terminals predicts a role in adjusting the activity of interneurons depending on the level of network activity.
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Introduction
The highly regulated distribution of neurotransmitter receptors
is an important determinant of neuronal networks. In particular,
the remarkable molecular diversity, cell-specific expression, and
discrete targeting to defined domains in the plasmamembrane of
glutamate and GABA receptors underlie neuronal information
processing.
Metabotropic glutamate receptors (mGluRs), heptahelical
transmembrane receptors coupled to G-proteins, are encoded by
eight different genes and contribute in regulating neuronal excit-
ability and synaptic transmission (Nakanishi et al., 1994; Conn
and Pin, 1997). In the hippocampus, mGluRs are expressed in a
cell type-specific and subcellular domain-specific manner
(Shigemoto et al., 1996, 1997; Somogyi et al., 2003; Ferraguti et
al., 2004). Based on phylogenetic analysis, intracellular coupling,
and pharmacology (Conn and Pin, 1997; Joost and Methner,
2002), mGluRs can be subdivided into three structurally and
functionally homologous subgroups: group I (mGluR1 and
mGluR5), primarily located postsynaptically (Baude et al., 1993;
Lujan et al., 1996); group II (mGluR2 andmGluR3), present both
postsynaptically and presynaptically outside the release site
(Shigemoto et al., 1997; Tamaru et al., 2001); and group III
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(mGluR4, mGluR6–mGluR8), found in the presynaptic active
zone (Shigemoto et al., 1996; Shigemoto andMizuno, 2000; Corti
et al., 2002; Somogyi et al., 2003).
A consequence of group III mGluR activation is the depres-
sion of both glutamatergic and GABAergic transmission (Schoepp,
2001). The complement of different group III mGluRs at distinct
synapses plays a differential role in determining the specific phys-
iological behavior of neuronal responses (Shigemoto et al., 1996;
Scanziani et al., 1998; Evans et al., 2000; Semyanov and Kull-
mann, 2000). For example, in the hippocampal CA1 area, high
levels of mGluR4 (Corti et al., 2002; Kogo et al., 2004), mGluR7a
(Shigemoto et al., 1996, 1997; Kogo et al., 2004), and mGluR7b
(Somogyi et al., 2003) are present in the presynaptic active zone
of distinct sets of synapses with different dynamics. However, the
known location of group III mGluR subtypes cannot explain
pharmacological results on the regulation of synaptic transmis-
sion by this class of receptors (Scanziani et al., 1998; Semyanov
andKullmann, 2000; Losonczy et al., 2003; Kogo et al., 2004). The
reported results suggest a significant role for the high-efficacy
group III mGluRs, such as mGluR8, in regulating transmitter
release depending on the identity of specific circuits. Immunore-
activity for mGluR8a was predominantly reported in the termi-
nation zone of the lateral perforant pathway in the dentate gyrus
andCA3 area, although scattered labeling was also found in other
strata of CA areas (Shigemoto et al., 1997; Kogo et al., 2004) with
unidentified synaptic partners.
The aim of the present study has been the definition of the
precise distribution of mGluR8 splice variants (Corti et al., 1998)
in the hippocampus in relation to synaptic sites and the charac-
terization of the neurochemical nature of the target neurons re-
ceiving mGluR8-expressing inputs. In addition, we report the
network-related firing patterns of an interneuron that belongs to
a nonpyramidal cell class selectively targeted by mGluR8a-
containing boutons. Preliminary results were published in ab-
stract form (Dalezios et al., 2001).
Materials andMethods
All procedures involving experimental animals were performed in accor-
dance with the United Kingdom Animals (Scientific Procedures) Act
1986 and associated procedures. All efforts weremade tominimize stress
to the animals and the number of animals used. For immunocytochem-
ical studies, 16 adult Wistar rats (300–400 g; Charles River, Margate,
Kent, UK) were deeply anesthetized with Sagatal (pentobarbitone so-
dium; 100 mg/kg, i.p.) and perfused transcardially with saline, followed
for 15 min by a fixative composed of 4% paraformaldehyde, 0.2%
picric acid, and 0.05% glutaraldehyde in 0.1 M phosphate buffer (PB), pH
7.2–7.4. For immunofluorescence studies, no glutaraldehyde was in-
cluded in the fixative. The brains were removed quickly, rinsed exten-
sively in PB, and sectioned in the coronal plane on a vibratome at 50m
thickness for immunofluorescence studies and at 70 m thickness for
electron microscopy.
Antibodies. A complete list of the primary and secondary antibodies,
including their dilution and combined use, used for this study is given in
Table 1. All secondary antibodies were purchased from commercial
sources (Table 1), as well as several primary antibodies: mouse anti-
vasoactive intestinal polypeptide (VIP) and rabbit anti-calretinin (CR)
from Biogenesis (Poole, UK); rabbit anti-VIP from Euro-diagnostica
(Boldon, UK); rat anti-muscarinic type 2 receptor (M2) and guinea pig
anti-substance P receptor (NK1) fromChemicon (Chandlers Ford, UK);
rabbit anti-mGluR1a from DiaSorin (Stillwater, MN); mouse anti-
parvalbumin (PV) from Sigma-Aldrich (Gillingham, UK); and rabbit
anti-calbindin (CB-38, lot 5.5), mouse anti-CR, and mouse and rabbit
anti-PV fromSwant (Bellinzona, Switzerland).Other primary antibodies
were kindly provided by the following: Dr. A. Buchan (Medical Research
Council Regulatory Peptide Group, Vancouver, British Columbia, Can-
ada), mouse anti-somatostatin (SOM) (Vincent et al., 1985); Dr. K.
Tanaka (Niigata University, Niigata, Japan), human anti-glutamic acid
decarboxylase (GAD) (Oe et al., 1996); Dr A. Varro (Liverpool Univer-
sity, Liverpool, UK), rabbit anti-procholecystokinin (CCK) (Morino et
al., 1994); Dr. K.G. Baimbridge (University of British Columbia, Van-
couver, British Columbia, Canada), guinea pig anti-PV (Ferraguti et al.,
2004); Dr. J. Polak (Imperial College, London, UK), rabbit anti-
neuropeptide Y (NPY) (Allen et al., 1983); and Dr. B. Gasnier (Centre
National de la Recherche Scientifique–Institut de Biologie Physico-
Chimique, Paris, France), rabbit anti-vesicular GABA transporter (VI-
AAT) (Dumoulin et al., 1999). The polyclonal antibodies against
mGluR7a, mGluR8b, and NK1, raised in rabbit, and mGluR8a, raised in
guinea pig, were generated and characterized as described previously
(Shigemoto et al., 1993, 1996, 1997; Kinoshita et al., 1996; Somogyi et al.,
2004).
Immunoblotting of cell membranes. To assess the specificity of the
mGluR8 isoform-specific antibodies, cDNAs encoding ratmGluR8a and
mGluR8b (Corti et al., 1998) were subcloned into the eukaryotic expres-
sion vector pcDNA3 (Invitrogen, San Giuliano Milanese, Italy) and
transfected into subconfluent CHO-K1 cells grown in DMEM (Life
Technologies, Paisley, UK) in the presence of 10% fetal bovine serum.
Transfections were performedwith a solution containing 10g of cDNA
and a 3:1 ratio of FuGene reagent (Roche Diagnotics, Rotkreuz, Switzer-
land) in 200 l of serum-free DMEM per 10 cm dish for 30 min. After
48 h, cells were harvested, resuspended with 200l of lysis buffer (20mM
Tris base, 150 mM NaCl, 50 M phenylmethylsulfonyl fluoride, 1 g/ml
leupeptin, 1g/ml pepstatin A, 1g/ml aprotinin, 1g/ml bacitracin, 10
g/ml bestatin, 1 g/ml antipain, and 1 g/ml chymostatin), and soni-
cated twice. All chemicals were purchased from Sigma (St. Louis, MO).
Total proteins of cell lysate (10 g/lane), quantified by the bicincho-
ninic acid protein assay (Pierce, Rockford, IL), were denatured in Lae-
mmli sample buffer containing 20 mM dithiothreitol (DTT) and heated
for 3 min at 60°C for SDS-PAGE on an 8% resolving gel. Proteins were
then electrophoretically transferred to polyvinylidene difluoride mem-
branes (Hybond P; Amersham Biosciences, Little Chalfont, UK). Blots
were blocked for 1 h in 5% dried skimmed milk in 0.9% NaCl buffered
with 50 mM Tris (TBS)–0.1% Tween 20 and incubated overnight at 4°C
with anti-mGluR8a (0.6 g/ml) or anti-mGluR8b (0.5 g/ml) antibod-
ies. Immunodetection was performed with secondary antibodies [1:2000
anti-rabbit IgG fromdonkey,NA934 (AmershamBiosciences); or 1:1000
anti-guinea pig IgG from rabbit, P0141 (Dako, Glostrup, Denmark)]
conjugated to horseradish peroxidase (HRP) and performed by en-
hanced chemiluminescence (Amersham Biosciences).
Double- and triple-immunofluorescent experiments. Immunofluores-
cent experiments were performed according to procedures published
previously (Ferraguti et al., 2004). Briefly, free-floating sections were
incubated in blocking solution [TBS, pH 7.4, 0.1% Triton X-100 (TX),
and 20% normal goat serum (NGS)] for 1 h and then in primary anti-
bodies (see Table 1 for complete listing and dilutions), in combination or
alone, diluted in TBS, 0.1% TX, and 1% NGS for 48 h (4°C). Subse-
quently, after extensivewashes in TBS, sectionswere incubated overnight
(4°C) with a mixture of appropriate secondary antibodies (Table 1).
When biotinylated secondary antibodies were used, sections were subse-
quently incubated, after extensive washes in TBS, in a solution contain-
ing streptavidin conjugated to either 7-amino-4-methylcoumarin-3-
acetic acid (1:1000; Vector Laboratories, Burlingame, CA) or Cy5 (1:
1000; Amersham Biosciences) diluted in TBS–0.1% TX. When
biotinylated HRP-conjugated secondary antibodies were used, sections
were subsequently incubated, after extensive washes in TBS, in the FITC-
tyramide reagent (PerkinElmer Life Sciences, Boston, MA) diluted 1:50
in amplification diluent for 10 min. Sections were then mounted onto
gelatin-coated slides in Vectashield (Vector Laboratories).
Image acquisition and analysis. Immunofluorescencewas studied using
a Leitz (Wetzlar, Germany) DMRB microscope with epifluorescence il-
lumination equippedwith the following filter blocks: A4 (excitation filter
band pass (BP), 360/40 nm; reflection short-pass filter, 400 nm; suppres-
sion filter BP, 470/40 nm), L5 (excitation filter BP, 480/40 nm; reflection
short-pass filter, 505 nm; suppression filter BP, 527/30 nm), Y3 (excita-
tion filter BP, 545/30 nm; reflection short-pass filter, 565 nm; suppres-
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sion filter BP, 610/75 nm), and Y5 (excitation filter BP, 620/60 nm;
reflection short-pass filter, 660 nm; suppression filter BP, 700/75 nm).
Images, recorded through a CCD camera (model C4742-95;
Hamamatsu, Welwyn Garden City, UK), were analyzed and displayed
using the Openlab software (version 3.1.4; Improvision, Coventry, UK).
Brightness and contrast were adjusted for the entire frame, and no part of
a frame wasmodified in any way. For the colocalization of mGluR7a and
mGluR8a immunolabeling in terminals, specimens were analyzed with a
Zeiss (Oberkochen, Germany) LSM 510/Axiovert 100M confocal
microscope.
Immunocytochemistry for electron microscopy. The immunocytochem-
ical procedures were identical to those described previously (Dalezios et
al., 2002). Floating sections were first incubated for 1 h in 20% NGS
diluted in TBS. Sections were then incubated with primary antibodies
(Table 1) in TBS containing 1% NGS, at least overnight or for several
days. When a single primary antibody was used, it was visualized either
by an immunoperoxidase method or by silver-intensified immunogold
reaction. When more than one primary antibody was used, one of them
was visualized by immunoperoxidase reaction and the second one was
visualized by silver-intensified immunogold reaction. After primary an-
tibody incubation, the sections were incubated overnight at 4°C in one,
or in a mixture, of the secondary antibodies (Table 1). Fab fragment IgG
coupled to 1.4 nm gold was purchased from Nanoprobes (Stony Brook,
NY). After several washes in TBS, when required, the sections were
Table 1. Summary of the concentrations and combinations of primary and secondary antibodies
Primary antibodies Species (raised in) Dilution Secondary antibodies Dilution Reactions
mGluR8a Guinea pig 1:500 Gt anti-GP biotina 1:100 27, 30, 31, 32, 33
1:500 Gt anti-GP nanogoldb 1:100 26
1:500 Gt anti-GP Alexa 488c 1:1000 3, 4, 5, 7, 11, 12, 13, 14, 17, 21, 24, 34
1:500 Dnk anti-GP FITCd 1:400 8, 9
1:500 Dnk anti-GP Cy3TMd 1:400 1, 10, 15, 16, 18, 19, 20, 22, 23, 25
mGluR8b Rabbit 1:200 Dnk anti-Rb Cy3TMd 1:400 2, 3
1:200 Gt anti-Rb Alexa 488c 1:1000 6
1:200 Gt anti-Rb biotina 1:100 28
1:200 Gt anti-Rb nanogoldb 1:100 29
CCK Rabbit 1:1000 Dnk anti-Rb Cy3TMd 1:400 14
CR Mouse 1:500 Gt anti-Ms Cy3TMd 1:400 13
1:2000 Gt anti-Ms Alexa 488c 1:1000 23
1:2000 Gt anti-Ms AMCAe 1:100 20
1:2000 Gt anti-Ms Cy5TMf 1:500 21, 24
CR Rabbit 1:800 Dnk anti-Rb Cy3TMd 1:400 9, 35
1:800 Gt anti-Rb Cy5TMf 1:1000 10, 22
Calbindin Rabbit 1:10,000 Dnk anti-Rb Cy3TMd 1:400 11
1:10,000 Dnk anti-Rb Cy3TMd 1:400 34
GAD Human 1:1000 Gt anti-HS nanogoldb 1:100 30
M2 Rat 1:250 Gt anti-Rat Cy3TMd 1:400 4, 5, 6
1:250 Gt anti-Ms Cy5TMd 1:500 7, 36
1:250 Gt anti-Ms biotina 1:100 8, 9, 11
1:500 Dnk anti-Rat Cy2TMd 1:400 10
1:200 Gt anti-Ms nanogoldb 1:100 32
mGluR1a Rabbit 1:500 Gt anti-Rb nanogoldb 1:100 33
1:500 Gt anti-Rb Cy5TMf 1:1000 5
1:500 Gt anti-Rb Alexa 488c 1:1000 15, 16, 19, 20
1:500 Dnk anti-Rb Cy3TMd 1:400 7, 17, 21, 34, 37
mGluR7a Rabbit 1:500 Dnk anti-Rb Alexa 488c 1:1000 18
1:500 Dnk anti-Rb Cy3TMd 1:400 36
NK1 receptor Rabbit 1:1000 Dnk anti-Rb Cy3TMd 1:400 34
NK1 receptor Guinea pig 1:500 Gt anti-Gp Alexa 488c 1:1000 35
NPY Rabbit 1:2000 Dnk anti-Rb Cy3TMd 1:400 35
PV Mouse 1:10,000 Hrs anti-Ms biotina 1:100 17
1:10,000 Gt anti-Ms AMCAe 1:100 16
PV Guinea pig 1:1000 Gt anti-GP Alexa 488c 1:1000 35
SOM Mouse 1:500 Gt anti-Ms biotina 1:100 8
1:500 Gt anti-Ms Cy3TMd 1:400 12
1:500 Gt anti-Ms AMCAe 1:100 15
1:500 Gt anti-Ms Cy5TMd 1:500 18, 34, 35
Streptavidin–AMCA 1:1000 Streptavidin–AMCAa 1:1000 25, 34, 35, 36, 37
VIAAT Rabbit 1:2000 Gt anti-Rb nanogoldb 1:100 31
VIP Mouse 1:10,000 Gt anti-Ms AMCAe 1:100 19
1:10,000 Gt anti-Ms Alexa 488c 1:1000 22
VIP Rabbit 1:2000 Dnk anti-Rb Cy3TMd 1:400 24
1:2000 Gt anti-Rb Cy5TMf 1:1000 23
Gt, Goat; Dnk, donkey; Ms, mouse; Rb, rabbit; Hrs, horse; GP, guinea pig.
aPurchased from Vector Laboratories.
bPurchased from Nanoprobes.
cPurchased from Invitrogen (Eugene, OR).
dPurchased from Jackson ImmunoResearch (West Grove, PA).
ePurchased fromMP Biomedicals (Irvine, CA).
fPurchased from Amersham Biosciences.
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washed in double-distilled water, followed by silver enhancement of the
gold particles with an HQ Silver kit (Nanoprobes) for 8–12 min. Subse-
quently, the sections were incubated in avidin-biotinylated HRP com-
plex (diluted 1:100; Vector Laboratories) in TBS overnight at 4°C and
washed in Tris buffer, pH 7.4. Peroxidase was visualized with 3–3-
diaminobenzidine (DAB; 0.5 mg/ml) using 0.01% H2O2 as substrate for
5–10min. Sections were then treated with 2%OsO4, contrasted with 1%
uranyl-acetate, and embedded in epoxy resin (Durcupan ACM, Fluca;
Sigma-Aldrich, Gillingham, UK). Ultrathin (70- to 80-nm-thick) serial
sections were collected on pioloform-coated copper grids and analyzed
in a Philips (Eindhoven, The Netherlands) CM100 electron microscope.
Unless stated otherwise, samples were obtained at least from two differ-
ent rat brains, and two blocks of each animal were cut for electron
microscopy.
Controls.To test antibody andmethod specificity in the procedures for
light or electron microscopy, antisera against mGluR1a, mGluR7a,
mGluR8a, and mGluR8b used in this study were tested on brain slices of
mice lacking the respective receptor [brains of receptor-null mice were
kindly provided by Dr. F. Conquet (Institut de Biologie Cellulaire et de
Morphologie, Universite´ de Lausanne, Lausanne, Switzerland), Dr. R.
Duvoisin (Neurological Sciences Institute, Oregon Health & Science
University, Portland, OR), and Dr. Van der Putten (Neuroscience Re-
search, Novartis Institutes for Biomedical Research, Novartis Pharma
AG, Basel Switzerland)]. No immunolabeling for any of these antibodies
could be detected in sections ofmice lacking the respective receptor (data
not shown).
To control for a possible cross-reactivity between IgGs in double- and
triple-immunolabeling experiments, some sections were processed
through the same immunocytochemical sequence, except that only one
primary antibody was applied; but the full complement of secondary
antibodies was maintained. In addition, the secondary antibodies used
were highly pre-adsorbed to the IgGs of numerous species.
In situ hybridization. In situ hybridization experiments were per-
formed as described previously (Shigemoto et al., 1992; Ohishi et al.,
1993). Briefly, adult male Sprague Dawley rats (n 2; 250–300 g) were
deeply anesthetizedwith ether and decapitated. The brainswere removed
quickly and frozen in isopenthane at 70°C. Brains were subsequently
cut at 10 m thickness on a cryostat and thaw-mounted onto poly-L-
lysine-coated slides. Sections were fixed with 4% paraformaldehyde in
0.1 M PBS for 10 min, rinsed in PBS, and acetylated with 0.25% acetic
anhydride in 0.1 M triethanolamine/0.9% NaCl for 10 min at room tem-
perature. After dehydration in an ascending ethanol series, the sections
were air dried and stored at 80°C until use. Sections were hybridized
with 35S-labeled antisense riboprobe corresponding to the 1–1378 bp of
rat mGluR8 (GenBank accession number U63288). Hybridization was
performed in 50% formamide, 2 SSC, 10 mM Tris-Hcl, pH 7.5, 1
Denhardt’s solution, 10% dextran sulfate, 0.2% SDS, 100 mM DTT, 500
g/ml sheared single-stranded salmon spermDNA, and 250g/ml yeast
tRNA. The riboprobes were preheated at 80°C for 3 min in 1 M DTT and
diluted in hybridization buffer to 1 105 cpm/l before application to
the sections. Hybridization was performed at 57°C for 5 h. Slides were
washed in 2 SSC and 10 mM -mercaptoethanol at room temperature
and then at 60°C for 1 h. Sections were treated with 20g/ml RNase A in
0.5 M NaCl, 10 mM Tris-Hcl, pH 7.5, and 1 mM EDTA, followed by an
additional wash at a final stringency of 0.1 SSC at 60°C for 1 h. After
dehydration in ethanol, sections were air dried and exposed to Amer-
sham Biosciences Beta-max films or dipped in NTB2 emulsion diluted
1:1 in distilled water. After exposure for 3–6 weeks at 4°C, the dipped
slides were developed in Kodak (Rochester, NY) D-19 developer, fixed,
and counterstained with cresyl violet. Control experiments were done in
adjacent sections with the same labeled riboprobe in the presence of
100-fold excess unlabeled probe.
In vivo recordings.Amale SpragueDawley rat (320 g) was anesthetized
with 0.42 g of urethane, plus supplemental doses of ketamine and xyla-
zine (20 and 2 mg/kg, respectively) as needed; body temperature was
maintained with a heating pad. Neuronal activity in the hippocampus
was recorded extracellularly with a glass electrode (25 M) filled with
1.5% neurobiotin in 0.5 M NaCl, and the local field potential (LFP) was
recorded with the same electrode. Single-unit activity (sampling rate, 20
kHz) and LFP (sampling rate, 800 Hz) were filtered on-line between 0.8
and 5 kHz and direct current-220 Hz, respectively.
Physiological data analysis. Theta epochs were detected by calculating
the theta (3–6Hz) to  frequency (2–3Hz) power ratio in 2 s windows of
the LFP (Csicsvari et al., 1998). A ratio 4 in at least three consecutive
windows marked theta episodes, and a ratio2 in at least three consec-
utive windows indicated epochs that are called non-theta/non-sharp
wave periods, which, in addition, lacked field ripples. Non-theta/non-
sharpwave periods contained oscillations of 1Hz and/or 2–3Hzbutwere
not further analyzed in this study, because of the large variability in cell
activity and LFPs. The exact beginning and end of these periods were set
manually.
The LFP was filtered at 90–140 Hz for the detection of sharp wave-
associated ripples, and the power (root mean square amplitude) of the
filtered signal was calculated in 10 ms windows. The threshold for ripple
detection was set to 5 SDs above the mean power. The beginning and the
end of the sharp wave were set at which the power crossed 1 SD above the
mean power. The highest oscillation amplitude was detected bymeans of
a peak-finding algorithm. To evaluate the firing pattern of the neuron
during sharp waves, ripple episodes were normalized. Because sharp
waves are often not symmetric, the periods between the beginning of the
ripple and the ripple maximum, and between the ripple maximum and
the end of the ripple episode, were each divided into four bins, and spikes
were sorted into bins. To determine the phase relationship between sin-
gle spikes and the phase of theta or ripple cycles, the troughs of the
oscillations were detected in the filtered signal (3–6 or 90–140Hz). Each
spike was assigned to a given phase (bin size, 18 or 36°) between the
troughs (0 and 360°), and all cycles were superimposed. Theta and ripple
phases were analyzed using circular statistics. The discharge frequency of
the cell during three different brain states (theta, sharp wave, and non-
theta/non-sharp wave) was calculated by dividing the number of spikes
by the summed duration of the respective brain state (Klausberger et al.,
2003).
Labeling and visualization of in vivo recorded cell.After the collection of
a sufficient number of spikes, the electrode was advanced toward the cell,
and the cell was labeled juxtacellularly with neurobiotin by applying
positive current steps (Pinault, 1996). Four hours after labeling, the rat
was perfused with the same fixative as described above. Coronal sections
of 65 m were cut on a vibratome. The labeled cell was then tested
according to procedures published previously (Klausberger et al., 2003,
2004). Immunofluorescence experiments were performed as described
above. Sections containing processes of the cell were incubated with
AMCA-conjugated streptavidin (1:1000; Vector Laboratories) together
with three different primary antibodies, followed by appropriate second-
ary antibodies (Table 1). When the cell was found immunonegative for a
certain antibody, the result was well documented by taking several digital
photographs, and on several occasions, the same section was re-reacted
with a different primary antibody but the same secondary antibody. In
each re-reaction, we checked the tissue in general, not only the labeled
cell, for the appearance of new signals resulting from the new antibodies.
Only if novel immunopositive cells and/or processes appeared in the
appropriate fluorescence channel was the labeled cell evalutated for the
second or third tier of molecules. Cells or parts of cells were considered
immunonegative for amolecule when fluourescence was undetectable in
the tested cell in an area where other cells were immunopositive.
All sections containing processes of the cell (also including those de-
veloped for immunofluorescence) were processed for visualization of
neurobiotin by an HRP reaction end product to reconstruct the cell. For
electron-microscopic analysis, all filled terminals found were photo-
graphed, and the nature of the postsynaptic target was determined.
Results
Labeling for the two mGluR8 splice variants, mGluR8a and
mGluR8b, was highly specific as shown byWestern immunoblot
data (Fig. 1A). Their respective immunoreactivity in the hip-
pocampal formation of adult rats was entirely overlapping and
highly discrete. Prominent immunostaining in the outer molec-
ular layer of the dentate gyrus and stratum lacunosum molecu-
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lare of the CA3 field (Fig. 1B) confirmed
and extended a previous study (Shigemoto
et al., 1997). In addition, somata and den-
drites in the subiculum, CA1, and CA3
subfields were also observed outlined by
numerous intensely immunofluorescent
puncta (Fig. 1C–E). This labeling, consis-
tent with a presynaptic location, was
highly selective for a subpopulation of
neurons in the stratumoriens/alveus of the
CA1 field with somata and dendrites ori-
ented horizontally (Fig. 1C,D). Labeling
for both mGluR8a and mGluR8b ap-
peared always to coexist in the same termi-
nals (Fig. 1D). Some neuronal profiles in
the stratum pyramidale and radiatum also
appeared to be associatedwithmGluR8 la-
beling, although to a lesser extent com-
pared with the stratum oriens/alveus. In
addition, a number of dendritic profiles sur-
rounded by puncta immunolabeled for
mGluR8 were observed at the border be-
tween the stratum radiatum and lacunosum
moleculare (data not shown). In the CA3
area, neurons strongly outlined by
mGluR8a- and mGluR8b-immunopositive
boutons were commonly observed within
the pyramidal cell layer (Fig. 1E,F).
Distribution of mGluR8
immunoreactivity in nerve terminals
The presynaptic location of mGluR8a and
mGluR8b in the hippocampal CA1 area
was tested by immunoelectron micros-
copy with either immunoperoxidase or
silver-intensified immunogold methods.
Labeling was restricted to boutons, which
formed either type I (asymmetrical) syn-
apses on dendritic shafts or type II (sym-
metrical) synapses on dendritic shafts and
somatic profiles (Fig. 2). Immunogold particles were confined to
the presynaptic active zone (Fig. 2A,C,E,G,H), whereas the
amorphous electron opaque peroxidase product also diffused be-
tween presynaptic vesicles, filling, in some cases, the entire termi-
nal (Fig. 2B,D,F). Each individual dendritic profile appeared to
receive predominantly only one type of mGluR8-
immunopositive synapses (Fig. 3). This observation was con-
firmed for mGluR8a by quantitative analysis of dendrites located
in the stratum oriens/alveus. Only dendritic profiles receiving at
least one type I and one type II synapse on the sampled segment
were included in the analysis, and each synapse was assessed in
several consecutive sections to test whether they were immu-
nopositive or not. Under these sampling criteria, we encountered
19 dendritic profiles, receiving 2–10 synapses each. Five pos-
sessed type I immunopositive synapses only, 12 received immu-
nopositive terminals making type II synapses only, and only two
had both type I and type II immunoreactive terminals on them.
These dendrites are likely to belong to interneurons because they
received type I synapses, which are not present on the dendritic
shafts of pyramidal cells (Megias et al., 2001). To establish
whether the restricted presence ofmGluR8 in type I or II synapses
on distinct dendrites was different from random, we first ana-
lyzed the frequency of distribution of the two types of synapse in
the three different categories of mGluR8-decorated dendrites.
The frequencies of total type I or type II synapses did not differ
between categories of dendrites ( p 0.75; 2 test). The frequen-
cies of mGluR8-immunopositive and -immunonegative termi-
nals were also not different among the three categories of den-
drites ( p 0.05; 2 test). Therefore, our sampling procedure did
not favor the selection of specific terminals on some of the pro-
files. These findings allowed us to compute the expected occur-
rence of the four types of terminals (type I or type II, mGluR8a
positive or negative) on each of the 19 profiles in our sample, as
the product of the frequencies of the terminals.We found that the
observed frequencies differed from random ( p  0.05; 2 test).
When the expected versus the observed frequencies were tested
for each dendrite category, we found that for dendrites receiving
mGluR8-immunopositive terminals only in type II synapses, the
observed frequencies were significantly different ( p 0.0001; 2
test) from expected, whereas for the other categories, no statisti-
cally significant differences were obtained ( p 0.25; 2 test). In
conclusion, these findings indicate that some dendritic profiles
predominantly receive type II mGluR8a-immunopositive termi-
nals. Whether these profiles comprise a specific type(s) of inter-
neuron remains to be established.
In the stratum lacunosum moleculare, mGluR8-immuno-
Figure 1. Distribution of immunoreactivity formGlu8a/mGluR8b receptors in the hippocampus. The patterns ofmGluR8a and
mGluR8b immunofluorescence labelingwere entirely overlapping.A, Immunoblot testing of cross-reactivity between antibodies
tomGluR8a andmGluR8b.B, Intense labeling formGluR8b can be observed in the outer third of the dentatemolecular layer (Mol)
and in the stratum lacunosum moleculare of the CA3 area with a much weaker reaction in the CA1 area. C, D, Large boutons
strongly immunoreactive for both mGluR8a and mGluR8b (arrowheads) contact the soma and dendrites of horizontal interneu-
rons in the CA1 stratum oriens-alveus. Labeling for the two splice variants coexists in the same terminals (arrowheads; D). E, F,
Several interneurons in the CA3 subfield, mainly located in the pyramidal cell layer, are outlined by mGluR8a intensely immu-
nopositivepuncta (arrowheads;E). Scalebars:A,F, 150m;B–E, 30m.m.t.,Mock-transfected cells; Gr, granule cell layer; SLM,
stratum lacunosummoleculare; SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum.
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labeled terminals formed type I synapses with both dendritic
shafts (Fig. 2H) and spines (data not shown). Because of the
complete coexistence between the two alternatively spliced recep-
tors, most of the experiments described below were performed
only for the mGluR8a isoform, but we assume the results can be
extended to mGluR8b.
The GABAergic input to CA1 interneurons originates from
other local interneurons and the medial septum (Freund and
Buzsaki, 1996), whereas excitatory afferents arise from a variety
of intra- and extra-hippocampal sources that include CA3–CA1
pyramidal cells and projections from the entorhinal cortex, thal-
amus, and amygdala, respectively (Amaral and Witter, 1989;
Dolleman-Van Der Weel and Witter, 1996; Pikkarainen et al.,
1999). The local axon collaterals of CA1 pyramidal neurons
strongly express mGluR7a, which is selectively enriched in a tar-
get cell-dependent manner (i.e., higher levels are distributed to
the terminals that form synapses with SOM- and mGluR1a-
expressing neurons than to terminals making synapses with py-
ramidal cells or other types of GABAergic neurons) (Shigemoto
et al., 1996, 1997). To establish whether CA1 pyramidal cells also
express mGluR8 at their axon collaterals, we labeled several py-
ramidal neurons with neurobiotin by the in vivo juxtacellular
method (Pinault, 1996; Klausberger et al., 2003). We analyzed
201 filled boutons for the presence of mGluR8a immunoreactiv-
ity; of these, 200 did not show combined labeling, whereas for one
bouton, a conclusion could not be reached because it was close to
mGluR8-positive terminals. To investigate intra-hippocampal
sources of mGluR8 further, we analyzed by in situ hybridization
histochemistry the distribution of mGluR8 mRNA in the hip-
pocampus. A specific signal was limited to a few scattered neu-
rons in the stratum pyramidale and radiatum of CA fields (Fig.
4A,B), dentate granule cell layer, and hilus (data not shown),
which suggests a restricted expression of this receptor to some
local interneurons.
The GABAergic nature of some of the mGluR8a-immuno-
positive terminals forming type II synapses was confirmed by
double-labeling, pre-embedding experiments for electron mi-
croscopy, using immunoperoxidase (DAB) for mGluR8a to
maximize sensitivity and silver-intensified immunogold for
the GABA-synthesizing enzyme GAD (Fig. 4C) or the VIAAT
(Fig. 4D).
These results suggest that CA1 pyramidal cells do not express
mGluR8, and hence putative glutamatergic terminals containing
these receptors are likely to originate from extra-hippocampal
sources or CA3 pyramidal cells. Moreover, they indicate a re-
stricted expression of mGlu8 receptors by a subset of hippocam-
pal interneurons, which are the main candidate for the GABAer-
gic input.
Selective concentration of mGluR8 in terminals targeting
oriens/alveus interneurons expressing the muscarinic
acetylcholine M2 receptor
To identify the interneuron populations targeted by mGluR8-
positive terminals, we performed double- and triple-immuno-
fluorescence experiments combining antisera for mGluR8 and
molecular markers that selectively characterize subclasses of hip-
pocampal interneurons (Table 1). At least six different classes of
the oriens/alveus interneuron with the soma and dendrites ori-
ented horizontally have been described so far, which include
oriens-lacunosum moleculare (O-LM) cells (Baude et al., 1993;
McBain et al., 1994; Maccaferri et al., 2000), oriens bistratified
(O-Bi) cells (Ali and Thomson, 1998; Maccaferri et al., 2000),
trilaminar cells (Sik et al., 1995), muscarinic M2 acetylcholine
receptor-immunoreactive interneurons (Hajos et al., 1998), and
subsets of basket and axo-axonic cells (Ganter et al., 2004). These
interneurons differ in axonal projections and expression of neuro-
transmitter receptors, calciumbindingproteins, andneuropeptides.
Interneurons immunopositive for M2 receptors were the
main, but not the only, target of mGluR8a- and mGluR8b-
Figure2. Electronmicrographs showing immunoreactivity formGluR8aandmGluR8b in the
stratum oriens (A–G) and stratum lacunosum moleculare (H ) of the CA1 area. A, C, Immuno-
gold/silver labeling for mGluR8a is concentrated in the presynaptic active zone facing the
postsynapticmembrane specialization of type I (arrowhead;A) or type II (arrow; C) synapses on
dendritic shafts. B, D, Immunoperoxidase labeling for mGluR8b spreads from the presynaptic
membrane specialization in boutons forming a type I (arrowhead; B) or a type II (arrow; D)
synapse on dendritic shafts. E, Two axon terminals forming type II synapses (arrows) with the
perikaryon of a presumed interneuron show intense immunolabeling formGluR8a. F, The soma
of apresumed interneuron receives a type II synapse (arrow) fromanaxon terminal labeledwith
peroxidase immunoreactionproduct formGluR8b.G, A rare example of an interneurondendrite
receiving both a type I (arrowhead) and a type II (arrow) synapse immunolabeled formGluR8a.
The density of immunoparticles is much higher in the terminals forming the type I synapse. H,
The presynaptic active zone of a bouton making a type I synapse (arrowhead) with a dendritic
shaft in the stratum lacunosummoleculare is labeled with immunogold particles for mGluR8a.
Scale bars: A–D, G, H, 0.2m; E, F, 0.5m. At, Axon terminal; d, dendritic shaft; S, soma.
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positive boutons. The density of immuno-
reactive terminals was high on both the
soma and dendrites of these cells (Fig. 5A–
C). Not all M2-immunoreactive cells were
outlined with mGluR8a immunofluores-
cent boutons (Fig. 6C);10% of them (26
of 253M2-positive cells tested in CA1) did
not receive any innervation containing de-
tectable mGluR8 labeling. To establish the
type of synapses formed by mGluR8a-
containing terminals, immunoreactivity
formGluR8a was demonstrated by immu-
noperoxidase reaction, whereasM2 recep-
tors were demonstrated by silver-
intensified immunogold particles.
Immunoreactivity for theM2 receptor was
mainly found on the plasma membrane
and concentrated perisynaptically and, to
a lesser extent, on intradendritic mem-
branes (Fig. 5D–F). Axon terminal label-
ing for the M2 receptor was also detected,
as reported previously (Hajos et al., 1998).
These terminals were primarily present in
the perisomatic region of pyramidal cells,
although immunopositive terminals were
observed in the stratum oriens/alveus and
other laminas (data not shown). Boutons
immunolabeled for mGluR8a formed ei-
ther type I or type II synapses on M2-
positive dendrites (Fig. 5D–F ). Termi-
nals displaying both M2 and mGluR8a
immunoreactivity also made synapses
with M2-positive dendrites (Fig. 5E).
Oriens/alveus interneurons expressingM2 receptors are a het-
erogeneous population containing either the neuropeptide SOM,
the calcium-binding proteins CR or calbindin, or none of the
markers distinctive for recognized interneuronal populations
(Hajos et al., 1998). We performed triple-immunofluorescence
experiments combining antisera for mGluR8a, M2, and SOM,
CR, or calbindin (Table 1). The vast majority ofM2-positive cells
immunonegative for CR, calbindin, and SOM were outlined by
mGluR8a-positive terminals, yet a few did not appear to receive
terminals containing mGluR8a (Fig. 6C). Rare interneurons im-
munoreactive for both M2 and CR (eight cells; 5% of all M2-
positive cells in our sample) were consistently targeted by
mGluR8a-positive axon terminals (Fig. 6A). Some of the rare
M2–calbindin-positive neurons also appeared to receive
mGluR8a-immunolabeled terminals (Fig. 6B). Conversely, M2-
and SOM-immunoreactive cells (6 of 43 cells sampled) compris-
ing 14% of M2-positive cells, consistent with that reported by
Hajos et al. (1998), did not receive detectable mGluR8a-positive in-
nervation (Fig. 6D). The overlap of M2-, calbindin-, and SOM-
immunoreactive cells was not tested in the present study.
mGluR8-enriched innervation of a trilaminar cell
We attempted to determine the identity of the nonpyramidal
cells, which were innervated by stronglymGluR8a-positive nerve
terminals in the stratum oriens of the CA1 area. To this end, we
performed juxtacellular neurobiotin labeling of in vivo recorded
cells for the visualization of their processes, and immunofluores-
cence labeling for mGluR8a and several other molecules known
to be differentially expressed in nonpyramidal cells. Of 15
neurobiotin-labeled and tested cells in the stratum oriens, one
was surrounded by strongly mGluR8a-immunopositive boutons
(Fig. 7A–C). Because of the processing strategy, the soma of the
cell was not tested for mGluR8a. The tested proximal dendrites
were consistently followed by mGluR8a-positive dots, including
the thin dendritic branches. The section containing the somawas
tested for PV, CR, NK1 receptor, NPY, and SOM and was immu-
nonegative for all of these molecules (data not shown). One sec-
tion containingmany dendrites of the labeled cell was reacted for
mGluR1a and calbindin, and the dendrites were immunonega-
tive (data not shown). In another section, the dendrites were
shown to be immunopositive for M2 receptor and sparsely con-
tacted by mGluR7a-positive puncta (Fig. 7D,E), which probably
represent immunopositive nerve terminals innervating the den-
drite. After the immunoreactions, all of the sections were pro-
cessed for visualization of neurobiotin by HRP reaction, and the
cell was reconstructed.
The soma was located in the stratum oriens/alveus, and all of
the dendrites remained in this layer including the white matter,
oriented parallel with the layers (Fig. 8a). The dendritic field
covered930mmediolaterally and 1500manteroposteriorly
in the CA1 area and is among the largest fields in our sample of
cells (Fig. 8j). The dendrites were irregularly and sparsely spiny,
with most of the spines of the drumstick-shaped variety (Fig. 8c).
In the CA1 area and subiculum, the axon spanned 3.3 mm in
the rostrocaudal direction. The axon was most dense at the level
of the dendritic field and most widespread in the stratum oriens
passing into the stratum pyramidale. In the vicinity of the cell,
several major axon collaterals reached the border of the stratum
radiatum and lacunosum moleculare, where they turned back
and returned to the stratum oriens. Bouton-bearing collaterals
Figure 3. Electron micrographs of dendritic shafts in the CA1 stratum oriens receiving mGluR8-immunopositive boutons
forming either type I or type II synapses on each dendrite.A1–A3, Consecutive sections of twomGluR8a-containing boutons (At1
and At2) establishing type I synapses (arrowheads). B1–B2, Consecutive sections of two dendritic shafts (d1 and d2) receiving
mGluR8a-immunolabeled terminals forming only type II synapses (arrows). Scale bars, 0.2m. At, Axon terminal; d, dendritic
shaft.
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were present in all innervated layers and densest in the stratum
oriens (Fig. 8d,e). Based on the orientation of the soma, the lam-
inar distribution of the dendrites and the axon, this cell closely
resembled a cell described previously in a similar position and
named trilaminar cell (Sik et al., 1995). Although other prop-
erties cannot be directly compared in the two studies, we
maintain this terminology here and propose that the name
“trilaminar” is only applied to this specific cell type (Somogyi
and Klausberger, 2005) and not to other different cells that
have axons in three layers.
A surprising feature of the cell was an extensive projection to
the subiculum. Three main axon branches traveled caudally in
the alveus, giving short branches infrequently to the stratum
oriens and pyramidale and eventually branching extensively in all
layers and in a large area of the subiculum, including the molec-
ular layer. Another collateral proceeded in the alveus/fimbria to
the most-rostral pole of the hippocampus and was lost in the
stratum oriens; whether it left the hippocampus could not be
ascertained. In the stratum oriens and pyramidale of the CA1
area, interneurons were frequently and preferentially targeted on
the somata (Fig. 8g,h) and dendrites by multiple varicosities and
axonal branches. The interneurons could be identified because of
their elevated level of endogenous biotin revealed by the strepta-
vidin reaction. It appeared that only a select population of inter-
neurons was targeted, because next to well innervated cells, oth-
ers did not receive any contact from the axon. Selective
innervation of nonpyramidal cells was also observed in the sub-
iculum, but less frequently than in the CA1 area.
The cell exhibited low discharge frequencies during theta os-
cillations (0.2 Hz) (Figs. 8b, 9B,D) and non-theta/non-sharp-
wave episodes (0.1 Hz), but strongly increased its firing during
sharp wave-associated ripples (69.0 Hz) (Fig. 9A,C). Analysis of
the exact spike timing indicated that the cell fired with highest
probability at the highest amplitude of the ripple episodes (Fig.
9C), and at the ascending phase (122 	 60° after the trough) of
single ripple cycles recorded in the stratum pyramidale (data not
shown). During theta oscillations, the cell fired rarely but prefer-
entially on the trough of the theta cycles recorded extracellularly
in the stratum pyramidale. Unexpectedly, the interneuron fired
often with a complex spike burst (Figs. 8, 9), which is evident
from an increased firing probability at 2–3 ms in the autocorre-
logram of the spike times (Fig. 9E). These200 Hz spike bursts
are rather uncommon for interneurons but represent a hallmark
of pyramidal cells (Ranck, 1973).
In electron-microscopic serial section analysis of neurobiotin-
labeled varicosities, the synaptic specialization and the postsyn-
aptic target could not be identified for approximately half of the
varicosities studied, because the HRP end product covered the
extracellular space and obscured the synapses. Identification of
79 synapsesmade by the axon showed that the cellmainly formed
type II synapses (Fig. 9F–J). In four synapses made by the axon
(two in the CA1 area, two in the subiculum), the postsynaptic
density was much thicker than in the other synapses and similar
in thickness to the postsynaptic densities in pyramidal cell spines.
One of these synapses in the stratum radiatumand one synapse in
the subiculum were made by an axon collateral, which could be
shown tomake conventional type II synapses at other boutons. In
theCA1 area, postsynaptic targets were collected fromall layers at
an anteroposterior level close to the cell body (24 in the stratum
oriens, 30 in the stratum pyramidale, 9 in the stratum radiatum)
and were mainly dendritic shafts (n  47; 75%) and, to a lesser
extent, somata of both interneurons (n 4; 6%) and pyramidal
cells (n 12; 19%). Postsynaptic dendritic shafts of interneurons
(n 23) were identified by receiving type I synapses (Fig. 9G,H),
and they were 44% of identified postsynaptic targets. Pyramidal
dendrites (n  13; 25% of identified targets) were identified by
the presence of spines and/or small dense bodies (Fig. 9J) and/or
originating from a pyramidal cell body. Pyramidal cell bodies
(23% of identified targets in CA1, 19% of all targets) only re-
ceived type II synapses and contained small dense bodies,
whereas interneuron somata (8% in CA1) received both type I
and type II synapses and lacked dense bodies (Fig. 9F). A signif-
icant proportion of postsynaptic dendritic shafts (18% of targets
in CA1 and 75% of all targets in the subiculum) did not display
features that would have allowed the identification of the cell of
origin, within the section series analyzed. In total, in the CA1 area
out of the identified targets (n  52), 60% belonged to inter-
neurons and 40% belonged to pyramidal cells. A total of 16 syn-
apses were analyzed in the subiculum, and 4 synapses were iden-
tified as interneuron dendrites (Fig. 9H). It is likely that many of
the small andmedium-size unidentified dendritic shafts (n 12)
Figure 4. Localization of mGluR8 mRNA in the CA1 area by in situ hybridization histochem-
istry (A, B) and colocalization of mGluR8a with GAD (C) or VIAAT (D) in presynaptic boutons in
the CA1 stratum oriens/alveus. A, B, Bright-field photomicrographs of emulsion-dipped sec-
tions showing presumed interneurons (arrows), labeled for mGluR8 in the stratum pyramidale
and radiatum. C1–C3, Consecutive electron micrographs of presynaptic colocalization for GAD
(immunogold/silver particles) and mGluR8a (immunoperoxidase product) in an axon terminal
establishing a type II synapse (arrow) with a dendritic shaft. D1–D3, Colocalization between
VIAAT (immunogold/silver particles) andmGluR8a (immunoperoxidase) in serial sections of an
axon terminal (At1) establishing a type II synapse (arrow) with a dendritic shaft also receiving
an immunonegative terminal (At2) forming a type I synapse (arrowhead). Scale bars: A, B, 50
m; C, D, 0.2m. At, Axon terminal; d, dendritic shaft; SP, stratum pyramidale; SR, stratum
radiatum.
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originated from pyramidal cells, but their origin could not be
ascertained.
Because of the extensive axonal projection to the subicu-
lum, which is a well known target of CA1 pyramidal cells, the
infrequent type I synapses made by this cell, and the very high
density of axons around the cell body, some of the axons could
have originated from a pyramidal cell, the cell body of which
was not labeled. Therefore, in the subiculum, we serially sec-
tioned nine neurobiotin-labeled boutons of a juxtacellularly
labeled CA1 pyramidal cell. All synapses made by the pyrami-
dal cell axon were of type I with extensive postsynaptic densi-
ties, and the postsynaptic targets were dendritic spines (n 8)
and a dendritic shaft. Thus, both the synapse type and the
targets are different from the trilaminar cell axon, excluding
accidental pyramidal axon contribution to the subicular pro-
jection of this cell.
Figure 5. Specific targeting of interneurons expressing a high level of themuscarinic acetylcholineM2 receptor by intenselymGluR8-immunoreactive terminals.A–C, Fluorescencemicrographs
showing interneurons immunolabeled for the M2 receptor (red) and receiving boutons immunopositive for mGluR8a or mGluR8b (green) on soma and dendrites in the CA1 stratum oriens/alveus
[mGluR8a (A) and mGluR8b (C)] and in the CA3 stratum pyramidale (mGluR8a; B). D1–D3, Consecutive electron micrographs showing an mGluR8a-immunoreactive (peroxidase product) bouton
establishing a type II synapse (large arrow) with a M2-immunoreactive (gold/silver particles; small arrows) dendritic shaft in the CA1 stratum oriens/alveus. E1–E3, Consecutive electron
micrographs showing an M2-immunoreactive (gold/silver particles; small arrows) dendritic shaft in the CA1 stratum oriens/alveus receiving a type II synapse (large arrow) from an axon terminal
immunoreactive for both mGluR8a (peroxidase labeled) and M2 (gold/silver particles) on the plasma membrane (small arrows). F1–F4, Consecutive electron micrographs showing a mGluR8a-
immunoreactive (peroxidase) bouton establishing a type I perforated synapse (arrowheads) with an M2-immunoreactive (gold/silver particles on the plasma membrane; small arrows) dendritic
shaft in the CA1 stratum oriens/alveus. Scale bars: A, B, 30m; C, 10m; D1–D3, E1–E3, 0.5m; F1–F4, 0.2m. At, Axon terminal; d, dendritic shaft.
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mGluR1a-expressing interneurons are targeted by terminals
immunopositive for mGluR8a
BesidesM2-positive cells, mGluR8a-positive terminals contacted
other interneurons, although these terminals were seemingly
fewer, the intensity of the immunofluorescence signal was lower,
and their size appeared generally smaller. Among these interneu-
rons, a fewCR-positive (Fig. 10A) or calbindin-positive cells (Fig.
10B), both M2 negative, had the soma and/or dendrites deco-
rated withmGluR8a-positive terminals. In addition, a small pop-
ulation (17%; 21 of 147 tested in CA1) of CCK-positive cells
receivedmGluR8a-immunolabeled boutons onto their dendrites
and, to a lesser extent, on the soma (Fig. 10C). For themajority of
CCK-containing neurons, no mGluR8a-positive terminals could
be detected on either the dendrites or the soma. The distribution
of the somata of the two groups was not different.
However, the most significant fraction of M2-immuno-
negative interneurons decorated by mGluR8a-containing termi-
nals was found to express mGluR1a (Fig. 11). These were most
clearly and frequently observed in the subiculum and in the im-
mediately adjacent stratum oriens of the CA1 area.More laterally
in the dorsal hippocampus,mGluR1a-positive neuronswere only
rarely apposed by mGluR8-labeled boutons. These cells were
scattered in both the stratum oriens and pyramidale, but some-
times they could also be seen in the radiatum (data not shown).
Interneurons expressing mGluR1a, similarly to M2-containing
interneurons, were recently shown to belong to different cell
Figure 6. Interneurons decorated bymGluR8a-positive terminals and expressingM2 recep-
tors are neurochemically heterogeneous in the CA1 stratum oriens. A, Immunofluorescence
images taken at the same focal depth show mGluR8a-containing (green) nerve terminals
around an interneuron coexpressing M2 receptors (blue) and CR (red). B, Images showing
mGluR8a-containing (green) nerve terminals surrounding an interneuron coexpressing M2 re-
ceptors (blue) and calbindin (red). The top right panels in A and B show superimposed images.
C, Of two M2-immunoreactive interneurons (green), only one is decorated by mGluR8a-
enriched (red) terminals.D, An interneuron (double arrowheads) expressing bothM2 receptors
in the membrane and SOM in the Golgi apparatus (both shown in red) is not innervated by
mGluR8a-positive terminals (green), but two other nearby M2-immunoreactive interneurons
immunonegative for SOM are richly decorated by mGluR8-positive boutons. Because the anti-
bodies against M2 receptors and SOM were raised in rat and mouse, respectively, anti-mouse
secondary antibodies visualized both primary antibodies. However, because of the subcellular
segregation of SOM and M2 receptors, we could always differentiate between the two signals.
Scale bars, 30m.
Figure 7. Neurochemical properties of a trilaminar cell as shown by immunofluorescence.
A–C, Series ofmicrographs taken at different focal depth and showingmGluR8a-enriched bou-
tons (green dots, arrows) innervating the dendrites identified by streptavidin–AMCA (blue) of
the cell shown in Figure 8. In addition to the two large dendrites, a small dendritic branch
(arrowhead; C) is also decorated bymGluR8a-positive terminals.D, E, Triple-color fluorescence
micrographs of one of the dendrites (arrowhead, streptavidin–AMCA, blue) showing a high
level of M2 receptor immunoreactivity (green) in the membrane and innervation by mGluR7a-
immunoreactivenerve terminals (arrows, red).Nearbydendrites,mainlyoriginating fromO-LM
cells, which are immunonegative for M2 receptor, are more densely surrounded by strongly
mGluR7a-positive terminals. Scale bar, 10m.
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classes, which include O-LM cells, O-Bi
cells, and interneurons selectively target-
ing other interneurons (IS) (Losonczy et
al., 2002; Ferraguti et al., 2004). Because
O-LM cells are known to express high lev-
els of postsynaptic mGluR1a receptors
(Baude et al., 1993), to contain both SOM
and PV (Klausberger et al., 2003; Ferraguti
et al., 2004) and also to be heavily deco-
rated by mGluR7a-containing terminals
(Shigemoto et al., 1996, 1997), we per-
formed a series of triple-immunolabeling
experiments combining antisera for these
markers (Table 1). Terminals containing
mGluR8a immunoreactivity unevenly in-
nervated mGluR1a-immunolabeled neu-
rons expressing SOM as well as PV (Fig.
11A,B). Thesewere frequently observed in
the subiculum but not elsewhere. Neurons
intensely immunolabeled for PV, but not
for mGluR1a, were never decorated by
mGluR8a-positive terminals (Fig. 11B).
The vast majority of SOM-positive
neurons in the stratum oriens/alveus
were richly innervated by mGluR7a-
immunopositive terminals, but only a few
of them, with the exception of the subicu-
lum, appeared outlined by mGluR8a-
immunopositive terminals. However,
several oriens/alveus interneurons immu-
nonegative for SOM were seen decorated
by terminals labeled for mGluR7a and
mGluR8. In some cases, the labeling for
the two receptors appeared colocalized in
the same terminal (Fig. 12A).
Double-immunocytochemical experi-
ments for electron microscopy were per-
formed to elucidate the type of synapses
formed by mGluR8a-containing terminals
onto mGluR1a-immunoreactive interneu-
rons. Immunoreactivity for mGluR8a was
demonstrated by immunoperoxidase reac-
tion, whereas the one for mGluR1a was
shown by silver-intensified immunogold
particles. Immunoreactivity for mGluR1a
wasmainly found on the plasmamembrane
and concentrated perisynaptically. Termi-
nals immunolabeled for mGluR8a formed
either type I (Fig. 11E) or type II (Fig. 11D)
synapses onmGluR1a-positive dendrites.
We also investigated by immunofluo-
rescence whether interneurons displaying
immunoreactivity for mGluR1a and re-
ceiving mGluR8a-positive terminals also
contained CR and/or VIP, because
mGluR7a is strongly expressed in VIP-
positive GABAergic boutons (Somogyi et
al., 2003). In the CA1 and CA3 stratum
pyramidale and radiatum, sporadic inter-
neurons decorated by mGluR8a-enriched boutons and coex-
pressing mGluR1a and CR could be observed (Fig. 12B). In ad-
dition, terminals in the stratum oriens/alveus contained both
mGluR8a and VIP (Fig. 12C).
Discussion
A striking innervation of GABAergic neurons by mGluR8-
expressing presumed glutamatergic and GABAergic boutons has
been revealed in the hippocampus, in addition to the lateral per-
Figure8. Dendritic, axonal, and firingpatterns of a trilaminar cell (T85a) recorded in vivo and innervatedbymGluR8a-enriched
boutons in the CA1 area. a, Reconstruction of the cell with soma in the stratum oriens/alveus. The numbers in the top left corner
indicate section numbers (65 m thickness) collapsed into two-dimensional views of the axon. The dendrites (in red) mostly
remain in the stratum oriens and close to the white matter and are collapsed into the top panel from six sections (72–77); the
remainder of dendrites oriented perpendicular to the section plane are not shown in the other panels, for clarity. The axon (in light
blue) spread through all layers, except the stratum lacunosum moleculare, and was most dense and widespread in the stratum
oriens. Three main axon branches traveled caudally and branched extensively in all layers of the subiculum. Asterisks (in green)
mark continuation points of the axon in the subiculum. One axon collateral proceeded anterior in the white matter (data not
shown) and was lost in the most-anterior hippocampus. b, During theta activity, the cell rarely fired, but when it did, it fired in
bursts. c, Thedendriteswere sparsely spiny.d–i, Boutonswerepresent at highdensity alongaxon collaterals in the stratumoriens
(d), stratumpyramidale (e), stratum radiatum (f ), and in the subiculum (i). Both in the CA1 area and the subiculum, some axonal
branches innervated nonpyramidal cells on their soma (g, h) and dendrites viamultiple varicosities. Scale bars: a, 100m; c, 2.5
m; d–f, i, 10m; g, h, 5m. Calibration: b, 0.2 mV, 500 ms; inset, 10 ms. wm, White matter; or, stratum oriens; P, stratum
pyramidale; rad, stratum radiatum; l-m, stratum lacunosummoleculare; sub, subiculum; mol., molecular.
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forant path innervation of the dentate gyrus reported previously
(Shigemoto et al., 1997). Like other group IIImGluRs,mGluR8 is
selectively located in the presynaptic active zone of bothGABAer-
gic and glutamatergic terminals.We revealed the firing pattern of
one of the major mGluR8 recipient neurons, the trilaminar cell
that heavily innervates the subiculum in addition to theCA1 area.
We also provide the first account for the immunolocalization of
the other full-length alternatively spliced receptor isoform,
mGluR8b (Corti et al., 1998).
Distribution and subcellular location of group III mGluRs
The presence of mRNA for mGluR8 in the hippocampus was
demonstrated by reverse transcription-PCR (Corti et al., 1998),
but in situ hybridization either did not produce a detectable sig-
nal (Duvoisin et al., 1995; Corti et al., 1998) or showed wide-
spread expression including CA1–CA3 pyramidal cells (Saugstad
et al., 1997; Messenger et al., 2002). We detected a weak but
specific signal only in a few interneurons. Hence, the GAD- and
mGluR8-immunopositive terminals are likely to originate from
these interneurons. The previous negative results may be attrib-
uted to a lower sensitivity of the procedures. Conversely, the
reported signal in pyramidal neurons could be nonspecific label-
ing. Because of the intrinsic detection limit, we cannot rule out
expression of mGluR8 by pyramidal cells, particularly in CA3.
However, based on the overall evidence, we assume that
mGluR8-containing glutamatergic inputs originate primarily
from an extra-hippocampal source(s), like the entorhinal cortex,
amygdala, and thalamus (Amaral and Witter, 1989; Dolleman-
Van Der Weel and Witter, 1996; Pikkarainen et al., 1999). The
former two areas express relatively high levels of mGluR8 tran-
scripts (Corti et al., 1998), unlike the projection nuclei of the
thalamus (Saugstad et al., 1997; Corti et al., 1998; Messenger et
al., 2002).
The high concentration of mGluR8 in the input to specific
interneuron classes was also observed for other group III recep-
tors, such as mGluR7a (Bradley et al., 1996; Shigemoto et al.,
1996, 1997), mGluR7b (Somogyi et al., 2003), and mGluR4
(Corti et al., 2002). A target cell-specific enrichment of mGluR7a
was found in pyramidal cell axons innervating O-LM inter-
neurons versus pyramidal cells (Shigemoto et al., 1996, 1997;
Somogyi et al., 2003). A target cell-specific enrichment of
mGluR8 is suggested by the depression by L-2-amino-4-
phosphonobutyric acid (L-AP-4) of glutamatergic transmission
to GABAergic neurons but not to pyramidal cells at a concentra-
tion compatible with the activation ofmGluR8 (ormGluR4), but
not of mGluR7 (Scanziani et al., 1998). Although it is not known
whether GABAergic neurons also express presynaptic group III
mGluRs according to distinct targets along single axons, our pre-
vious and current findings are suggestive of some postsynaptic
influence also onto inhibitory axon terminals.
We found that the immunoreactivity for the two isoformswas
entirely overlapping not only in the hippocampal formation but
also in other telencephalic areas such as the piriform cortex, neo-
cortex, amygdala, and globus pallidus (data not shown). Thiscor-
responding distribution, together with their analogous intracel-
4
on small interneuron dendrites identified by an additional nearby type I synapse (double ar-
rows) in the stratum oriens (G) and the subiculum (H ). I, J, Synapses (arrows) received by the
soma (I ) and main apical dendrite (J ) of pyramidal cells in the CA1 area. The pyramidal cell
dendrite is identified by the presence of small dense bodies (small vertical arrow). The peroxi-
dase product spread into the synaptic cleft in I. Calibration: A, ripples, 0.05 mV; spikes, 0.5 mV,
50 ms; B, theta and spikes, 0.5 mV, 200 ms; inset, 10 ms. Scale bars: F–J, 0.2m.
Figure 9. Firing patterns and synaptic targets of the trilaminar cell.A, The cell fired (bottom
trace) at high frequency during sharpwave-associated ripple episodes (filtered 90–140Hz; top
trace).B, During thetaoscillations, the cell firedonlyoccasionally butoftenwitha complex spike
burst (*). C, The firing probability was greatest at the highest amplitude of the ripple episodes.
The start, highest amplitude, and end of the normalized ripple episodes are marked as1, 0,
and 1, respectively. D, The cell fired preferentially at the trough of the theta oscillations. For
clarity, the samedata are repeated in two theta cycles, inwhich 0° and360°mark the troughs of
the extracellularly recorded field potential oscillation. E, The autocorrelogram of spike times
during theta oscillations shows that the firing probability is increased 2–3 ms after/before a
spike. F–J, Synaptic targets of neurobiotin-labeled boutons visualized by peroxidase reaction.
F, Synapse (arrow) on an interneuron soma in the stratum pyramidale.G,H, Synapses (arrows)
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lular coupling properties and pharmacological profile (Corti et
al., 1998; Malherbe et al., 1999), suggests a heterodimerization of
the two isoforms.
Selective expression of mGluR8 in relation to specific
cell types
Themost prominent targets ofmGluR8-positive synapses are the
horizontal M2 receptor-immunoreactive neurons in the CA1
oriens/alveus and in the CA3 area. The mGluR8 decoration of
these cells is both denser and stronger than that of other cell types.
The visualization of the axon and dendrites of one of these cells
made it possible to identify them as the trilaminar cells (Sik et al.,
1995). The firing of complex spike bursts togetherwith the axonal
distribution, synapses onto pyramidal cell somata and onto a
high proportion of interneurons, and their septal projection
clearly separate this cell type from other interneurons (Somogyi
and Klausberger, 2005). Trilaminar cells are the fourth indepen-
dent identified source of GABA onto pyramidal cell somata
(Somogyi and Klausberger, 2005). The preferential targeting of
other interneurons by trilaminar cells, together with their high-
frequency firing on sharp wave-associated ripples, points to the
possibility that this cell might contribute to the specific silencing
of axo-axonic or O-LM cells (Klausberger et al., 2003), which are
inhibited during ripple episodes. Because O-LM cells are mostly
in the alveus/oriens, whereas the trilaminar cell targets were in
and around the pyramidal cell layer, axo-axonic cells are themost
likely candidates.
The source of excitatory drive to trilaminar cells is not known.
During theta activity, the prolonged glutamate release from all
hippocampal afferents would increase ambient glutamate levels
and activatemGluR8, leading to suppression of glutamate release
to trilaminar cells and hence contributing to their low firing rate.
During slow wave sleep and related brain states, the episodic
firing of pyramidal cells interspersed with long periods of low
activity would only increase glutamate levels during ripples, al-
lowing the trilaminar cells to be activated by glutamatergic affer-
ents, followed by mGluR8-mediated suppression. The firing of
trilaminar cells during ripples is in concert with basket and
bistratified cells, all innervating the pyramidal cell soma. During
theta activity, trilaminar cells would fire out of phase with basket
cells, but their low firing rate may not significantly contribute to
perisomatic pyramidal cell inhibition.
Both the density of terminals and the amount ofmGluR8were
distinctively lower in the input to other interneuron types com-
pared with M2 receptor-positive cells. Interneurons receiving
mGluR8 innervation and positive for mGluR1a, SOM, and
weakly for PV are probably O-LM cells (Shigemoto et al., 1996;
Klausberger et al., 2003; Ferraguti et al., 2004). A few other
mGluR8-decorated cells contained CR and may be IS (Freund
and Buzsaki, 1996; Ferraguti et al., 2004). The rare calbindin- or
CCK-positive neurons innervated by mGluR8 terminals may be-
long to the Schaffer collateral-associated interneurons expressing
both CCK and calbindin (Cope et al., 2002). The unambiguous
identification of these cells awaits visualization of their axonal
patterns.
The electron-microscopic analysis suggested that mGluR8-
expressing GABAergic and glutamatergic terminals targetmainly
separate postsynaptic cell types, possibly corresponding to spe-
cific subtypes of M2- and mGluR1a-positive interneurons. The
coexpression of VIP andmGluR8 ormGluR7a andmGluR8a in a
subset of terminals suggests that O-LM-like cells are their targets,
because O-LM cells receive strong GABAergic innervation from
VIP/mGluR7a-positive terminals of IS-III cells (Blasco-Ibanez
and Freund, 1995; Somogyi et al., 2003). An exception to the
segregation of GABAergic and glutamatergic inputs might be the
subclass of M2- and CR-positive interneurons (Freund and
Buzsaki, 1996) decorated by both mGluR7a- and mGluR8-
Figure 10. Interneurons in the CA1 area expressing CCK or the calcium-binding proteins CR
or calbindin but immunonegative for the M2 receptor, are decorated by mGluR8a-enriched
nerve terminals. A, Immunofluorescence superimposed images showing the soma of a CR-
immunopositive (red) neuron in the stratum oriens that is targeted by mGluR8a-enriched ter-
minals (green) but showed no M2 immunoreactivity (blue). B, A calbindin-expressing (red)
interneuron in the stratum pyramidale receives a dense innervation by mGluR8a-positive
(green) boutons mainly on the dendrites in the stratum radiatum. Inset, Higher-magnification
portion of a dendrite (arrowhead) contacted by labeled small boutons (arrows). C, A CCK-
expressing (red) interneuron in the stratum pyramidale is innervatedmainly on its dendrites in
the stratum radiatum bymGluR8a-containing (green) boutons. Scale bars: A, B, 30m; inset,
10m; C, 30m. SP, Stratum pyramidale; SR, stratum radiatum.
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Figure 11. Some terminals immunoreactive for mGluR8a target interneurons expressing mGluR1a in the stratum oriens/alveus. A, Fluorescence micrograph of triple-immunolabeling for
mGluR1a (red), SOM (blue), andmGluR8a (green) showing an interneuron (arrow) that is positive for mGluR1a in the plasmamembrane, positive for SOM in the Golgi apparatus, and decorated by
mGluR8a-immunopositive puncta. B, In this triple-fluorescence immunolabeling for mGluR1a (red), PV (blue), and mGluR8a (green), two interneurons (arrows) immunopositive for mGluR1a and
weakly positive for PV are decorated bymGluR8a-containing terminals. The interneuron strongly labeled for PV and immunonegative formGluR1a does not receive detectablemGluR8a innervation.
C, Triple-immunolabeling formGluR1a (red),muscarinicM2 receptor (blue) andmGluR8a (green). No coexistence betweenmGluR1a andM2 receptors could bedetected. Terminals immunopositive
for mGluR8a decorate dendrites immunolabeled either for mGluR1a (arrow) or M2 (arrowhead). D1, D2, Consecutive electron micrographs showing an mGluR8a-immunoreactive (peroxidase
product) bouton (At1) establishing a type II synaptic contact (large arrow) on the neck of a dendritic spine immunoreactive formGluR1a (gold/silver particles) (small arrows;D2). The dendritic shaft
receives two additional immunonegative boutons (At3, At4) also establishing type II synapses (large arrows;D1). E1–E3, Interneuron dendrites, immunoreactive formGluR1a (gold/silver particles;
small arrows) are shown in consecutive electron micrographs. Dendrite d1 receives an mGluR8a-positive (peroxidase product) axon terminal (At1), which along with two other immunonegative
boutons (At2, At3) establishes a type I synaptic junction (arrowheads). At, Axon terminal; d, dendritic shaft. Scale bars: A–C, 30m; D1, D2, 0.2m; E1–E3, 0.5m.
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enriched terminals, possibly representing
a subclass of IS interneurons. Cauli et al.
(2000) reported that among fusiform neo-
cortical interneurons, those displaying ir-
regular spiking and containing transcripts
for VIP and/or CR also frequently coex-
pressed mGluR8 and may be homologous
to hippocampal IS interneurons (Acsady
et al., 1996).
The role of group III mGluRs
In the presynaptic active zone of glutama-
tergic boutons,mGluR8 is probably an au-
toreceptor regulating glutamate release
(Baskys and Malenka, 1991; Desai et al.,
1994; Gereau andConn, 1995; Scanziani et
al., 1998), whereas in GABAergic termi-
nals, it may regulate heterosynaptically
GABA release (Gereau and Conn, 1995;
Poncer et al., 1995; Morishita et al., 1998;
Semyanov and Kullmann, 2000; Kogo et
al., 2004). We have shown recently that at
50 M L-AP-4 depressed IPSCs in oriens/
alveus interneurons, including identified
O-LM cells (Kogo et al., 2004), consistent
with the activation of mGluR8 (Wu et al.,
1998; Schoepp et al., 1999; Rosemond et
al., 2002). In pyramidal cells, IPSC depres-
sion was observed only at concentrations
300 M (Morishita et al., 1998; Semy-
anov and Kullmann, 2000; Kogo et al.,
2004), suggestive of a preferential action
on the low-affinity mGlu7 receptors (Wu
et al., 1998; Schoepp et al., 1999; Rose-
mond et al., 2002). Furthermore, the vari-
able depression of IPSCs in interneurons
(Kogo et al., 2004) indicated heterogeneity
of GABAergic inputs containing a differ-
ent complement of group III mGluRs.
Glutamatergic inputs to interneurons are
also suppressed by group III mGluR activa-
tion (Scanziani et al., 1998; Semyanov and
Kullmann, 2000; Losonczy et al., 2002). The
selective distribution of group IIImGluRs in
GABA terminals may underlie input-
specific, frequency, and/or time-dependent
regulation of hippocampal circuits.
Targeted deletion of the mGluR8 gene
in mice produces subtle behavioral alter-
ations such as reduced habituation to nov-
elty, hyperactivity, context-dependent but
not cue-dependent disruption of the freez-
ing response in the fear conditioning test
(Gerlai et al., 2002), and increased anxiety
(Linden et al., 2002). These alterations
point to an abnormal hippocampal func-
tion that, besides a reduced presynaptic
control of glutamate release from the lat-
eral perforant path onto granule cells
(Bushell et al., 1996; Shigemoto et al.,
1997; Zhai et al., 2002), will also result in
altered temporal patterns of GABA release
from interneurons.
Figure 12. Targets of boutons coexpresssing mGluR8a and mGluR7a or VIP in the stratum oriens/alveus. A, Series of confocal
microscopic images depicting mGluR8a-containing (green) and mGluR7a-containing (red) nerve terminals. In several boutons
(arrows) the immunolabeling for mGluR8a and mGluR7a coexists, whereas other boutons contain only one receptor. Right,
Superimposed images. B, Series of images showing mGluR8a-containing (green) nerve terminals contacting the soma of an
interneuron coexpressingmGluR1a (red) and CR (blue) and anmGluR1a-labeled dendrite (arrowheads). Top right, Superimposed
images. C, The soma of interneurons is innervated by boutons containing either VIP (green) or mGluR8a (red) or both molecules
(arrows). Scale bars: A, 5m; B, 50m; C, 10m.
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In summary, we have demonstrated thatmGluR8 is selectively
distributed in the hippocampal formation, which can explain
some of the complex and wide-ranging effects elicited by drugs
acting on group III mGluRs and the subtle behavioral effects
observed in mice lacking mGluR8.
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